Hormone response in ovarian cancer: time to reconsider as a clinical target?

Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression

(2012) Jing Zhu et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

Ovarian Cancer

(2012) Francesmary Modugno et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition

(2011) K K Tsilidis et al.   BRITISH JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer

(2011) Ilaria De Stefano et al.   GYNECOLOGIC ONCOLOGY

Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer

(2011) Ahmed Elattar et al.   GYNECOLOGIC ONCOLOGY

Distinct Expression Pattern of Dicer1 Correlates with Ovarian-Derived Steroid Hormone Receptor Expression in Human Fallopian Tubes during Ovulation and the Midsecretory Phase

(2011) Ruijin Shao et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma

(2011) Linda E Kelemen et al.   LANCET ONCOLOGY

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium

(2011) Galina Lurie et al.   PLoS One

Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer

(2011) Martin Ligr et al.   PLoS One

Reproductive and Hormonal Factors in Association With Ovarian Cancer in the Netherlands Cohort Study

(2010) M. G. M. Braem et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Fertility drugs and ovarian cancer risk: a critical review of the literature

(2010) Nikos F. Vlahos et al.   Annals of the New York Academy of Sciences

Advanced stage mucinous adenocarcinoma of the ovary is both rare and highly lethal

(2010) Richard J. Zaino et al.   CANCER

Estrogen receptor alpha pathway is involved in leptin-induced ovarian cancer cell growth

(2010) Jung-Hye Choi et al.   CARCINOGENESIS

17β-Estradiol Accelerates Tumor Onset and Decreases Survival in a Transgenic Mouse Model of Ovarian Cancer

(2010) Laura A. Laviolette et al.   ENDOCRINOLOGY

Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study

(2010) Jean A. Hurteau et al.   GYNECOLOGIC ONCOLOGY

Tubal ligation and the risk of ovarian cancer: review and meta-analysis

(2010) D. Cibula et al.   HUMAN REPRODUCTION UPDATE

Expressions of Estrogen and Progesterone Receptors in Epithelial Ovarian Cancer

(2010) Siriwan Tangjitgamol et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Hormonal Regulation and Distinct Functions of Semaphorin-3B and Semaphorin-3F in Ovarian Cancer

(2010) D. Joseph et al.   MOLECULAR CANCER THERAPEUTICS

Estrogen Receptor Subtypes in Ovarian Cancer

(2010) Karen K. L. Chan et al.   OBSTETRICS AND GYNECOLOGY

Expression of Membrane Progesterone Receptors (mPR/PAQR) in Ovarian Cancer Cells: Implications for Progesterone-Induced Signaling Events

(2010) Nathan J. Charles et al.   Hormones & Cancer

Androgen-related expression of G-proteins in ovarian cancer

(2009) L A Sheach et al.   BRITISH JOURNAL OF CANCER

Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin

(2009) Celeste Leigh Pearce et al.   CANCER

Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma

(2009) Lois M. Ramondetta et al.   CANCER

The Tamoxifen Metabolite, Endoxifen, Is a Potent Antiestrogen that Targets Estrogen Receptor   for Degradation in Breast Cancer Cells

(2009) X. Wu et al.   CANCER RESEARCH

Hormone therapy for epithelial ovarian cancer

(2009) Simon P Langdon et al.   CURRENT OPINION IN ONCOLOGY

Androgen, progesterone, and FSH receptor polymorphisms in ovarian cancer risk and outcome

(2009) Agnieszka Honorata Ludwig et al.   ENDOCRINE-RELATED CANCER

Progesterone Receptor Membrane Component-1 Regulates the Development and Cisplatin Sensitivity of Human Ovarian Tumors in Athymic Nude Mice

(2009) John J. Peluso et al.   ENDOCRINOLOGY

Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome)

(2009) Louise A. Brinton et al.   FERTILITY AND STERILITY

Induction of senescence by progesterone receptor-B activation in response to cAMP in ovarian cancer cells

(2009) Akira Takahashi et al.   GYNECOLOGIC ONCOLOGY

A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer

(2009) Peter A. Argenta et al.   GYNECOLOGIC ONCOLOGY

A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study

(2009) Thomas F. Rocereto et al.   GYNECOLOGIC ONCOLOGY

The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women

(2009) Kim N. Danforth et al.   INTERNATIONAL JOURNAL OF CANCER

Attenuated Sex Steroid Receptor Expression in Fallopian Tube of Women with Ectopic Pregnancy

(2009) Andrew W. Horne et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Ovarian Cancer

(2008) Kathleen R. Cho et al.   Annual Review of Pathology-Mechanisms of Disease

Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis

(2008) C L Pearce et al.   BRITISH JOURNAL OF CANCER

Loss of estrogen receptor β isoform expression and its correlation with aberrant DNA methylation of the 5′-untranslated region in human epithelial ovarian carcinoma

(2008) Fumihiko Suzuki et al.   CANCER SCIENCE

Epithelial ovarian cancer: testing the 'androgens hypothesis'

(2008) C. M Olsen et al.   ENDOCRINE-RELATED CANCER

Gonadotropin-releasing hormone and ovarian cancer: a functional and mechanistic overview

(2008) Wai-Kin So et al.   FEBS Journal

The relationship of endometriosis and ovarian malignancy: a review

(2008) Farr Nezhat et al.   FERTILITY AND STERILITY

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory

(2008) Zeina Nahleh   Future Oncology

Progesterone facilitates cisplatin toxicity in epithelial ovarian cancer cells and xenografts

(2008) William J. Murdoch et al.   GYNECOLOGIC ONCOLOGY

Efficacy of letrozole in the treatment of recurrent platinum- and taxane-resistant high-grade cancer of the ovary or peritoneum

(2008) Pedro T. Ramirez et al.   GYNECOLOGIC ONCOLOGY

Expression profile of heptahelical putative membrane progesterone receptors in epithelial ovarian tumors

(2008) Marisa Romero-Sánchez et al.   HUMAN PATHOLOGY

Regulation of Ovarian Cancer Cell Viability and Sensitivity to Cisplatin by Progesterone Receptor Membrane Component-1

(2008) John J. Peluso et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controls

(2008)   LANCET

Steroid-converting enzymes in human ovarian carcinomas

(2008) Justin C. Chura et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The Activity of Medroxyprogesterone Acetate, an Androgenic Ligand, in Ovarian Cancer Cell Invasion

(2008) Radhika Gogoi et al.   Reproductive Sciences